Johnson Johnson Rare spinal condition listed as side effect

Johnson & Johnson : Rare spinal condition listed as side effect Johnson & Johnson : Rare spinal condition listed as side effect

Europe’s drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson’s single-dose covid19 vaccine.

Reports of this serious neurological illness was also at the heart of trial halts in the early stages of development for both AstraZeneca and Johnson & Johnson’s shots, which are based on similar technology.

Dr. Macaya Douoguih, head of clinical development and medical affairs for J&J’s vaccines division Janssen, said there is no data to suggest people are at increased risk of a rare but serious blood clot condition after receiving a second dose.

A massive study comparing the real-world effectiveness of three COVID-19 vaccines (Pfizer, Moderna and J&J) over eight months has detected protection from infection may decline but protection from death holds strong. Tracking nearly 800,000 U.S. Veterans, the study found Johnson & Johnson’s single-dose vaccine showed the greatest decline.

Previous articleCovid19 â€" France has entered the 5th wave

Know What's Trending Today (Kwt Today) Web Desk reports news and views on trending topics from the Middle East and around the World.

Related Posts

0 Response to "Johnson Johnson Rare spinal condition listed as side effect"

Post a Comment